Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220009807 220004024 0.76 67.6 null 2018-12-27 2019-01-12 Cisplatin + Docetaxel +Fluorouracil N N 220036512 CYTARABINE + FLUDARABINE
220009808 220004025 1.63 0 Curative (C) 2015-11-16 2015-11-16 DABRAFENIB + TRAMETINIB 01 N 220011125 ARSENIC TRIOXIDE
220009809 220004026 1.66 -1 Curative (C) 2015-03-28 2015-04-03 Paclitaxel 7 day null null 220013532 FLUDARABINE + MELPHALAN
220009810 220004027 0 67 Disease modification (D) 2016-02-11 2016-02-13 Cyclophosphamide+Fludara+TBI Allo 02 N 220014565 MELPHALAN
220009811 220004028 1.8 null Palliative (P) 2016-01-12 2016-01-28 Fludarabine + Melphalan RIC Allo Y N 220020384 IPILIMUMAB
220009812 220004028 null null null 2017-04-11 2017-04-11 Arsenic trioxide + Tretinoin 99 N 220020384 CYCLOPHOSPHAMIDE + FLUDARABINE + MELPHALAN
220009813 220004028 1.33 null null 2014-05-18 2014-07-11 Triple / Double Intrathecal Therapy N null 220020384 FEC
220009814 220004029 1.67 114.5 Not known (9) null 2016-07-04 BEP 3 day null null 220021174 FEC
220009815 220004029 null null Disease modification (D) 2014-07-16 2014-07-30 CTD (Thalidomide 100mg) N N 220021174 FBC
220009816 220004030 null 20.9 null null 2016-04-07 Cyclophosphamide TBI Allograft null N 220023685 MITOXANTRONE + TRETINOIN
220009817 220004030 1.8 3.5 Palliative (P) 2017-05-25 2017-05-25 Arsenic Triox + Tretinoin Ind W1-4 2 null 220023685 MITOXANTRONE
220009818 220004030 1.55 37.7 Curative (C) 2019-01-19 2019-01-20 Temozolomide + RT 2 N 220023685 CYTARABINE + MITOXANTRONE
220009819 220004030 1.72 77.4 Curative (C) 2016-11-12 2016-11-13 Bendamustine + prednisolone N N 220023685 IDARUBICIN
220009820 220004031 null 75 Curative (C) 2018-08-29 2018-08-29 Ipilimumab 2 N 220027990 ALEMTUZUMAB
220009821 220004032 1.82 95 Palliative (P) 2016-12-11 2017-11-03 Cetuximab 7 day (>Cycle 2) N N 220028568 IPILIMUMAB
220009822 220004033 1.65 77.1 null 2012-12-28 2013-01-06 Cisplatin+Fluorouracil+Streptozoc N Y 220029487 CTD
220009823 220004034 1.63 0 Curative (C) 2017-08-03 2017-08-03 ATG + Busulfan + Fludarabine N N 220032071 FBC
220009824 220004035 null null Adjuvant (A) 2017-06-17 2017-06-19 Cyclophosphamide High Dose N N 220032351 CAPECITABINE + RT
220009825 220004036 null null Palliative (P) 2016-08-19 2016-08-19 FLUDARABINE null null 220032604 CAPECITABINE + EPIRUBICIN + OXALIPLATIN
220009826 220004037 1.6 42.3 Palliative (P) 2016-11-25 2016-12-05 METHOTREXATE N N 220035180 IPILIMUMAB + NIVOLUMAB
220009827 220004038 1.65 65.7 null null 2017-12-13 Triple / Double Intrathecal Therapy N null 220035471 CYCLOPHOSPHAMIDE HIGH DOSE
220009828 220004038 null null Palliative (P) 2018-10-28 2018-10-31 ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE N N 220035471 IPILIMUMAB
220009829 220004039 1.72 0 Curative (C) 2018-02-09 2018-02-09 Mitoxantrone Y N 220026545 SPIRIT TRIAL
220009830 220004039 null 88.6 Curative (C) 2015-08-28 2015-08-28 IDARUBICIN N N 220026545 BUSULPHAN
220009831 220004040 0 0 Disease modification (D) 2015-04-02 2015-04-02 Imatinib 400mg N N 220000001 IMATINIB
220009834 220004043 0 null Disease modification (D) 2013-12-23 2013-12-23 Imatinib 400mg 2 N 220000022 IMATINIB
220009835 220012143 1.83 0 Disease modification (D) 2015-03-27 2015-03-27 IMATINIB 2 N 220000089 IMATINIB
220009836 220004047 0 74.3 Disease modification (D) 2016-08-30 2016-08-30 IMATINIB 02 N 220000097 IMATINIB
220009837 220004047 1.56 58 Disease modification (D) 2016-04-26 2016-04-26 IMATINIB N N 220000097 IMATINIB
220009838 220004049 0 null Disease modification (D) 2013-04-24 2013-04-25 IMATINIB N N 220000120 IMATINIB
220009839 220004052 null 0 Disease modification (D) 2013-11-11 2013-11-14 IMATINIB null null 220000145 IMATINIB
220009840 220004056 0 76.4 Disease modification (D) 2018-01-25 2018-01-25 IMATINIB N N 220000151 IMATINIB
220009841 220012145 1.74 96.6 Disease modification (D) 2016-04-27 2016-04-29 IMATINIB N N 220000151 IMATINIB
220009842 220012145 null 84 Disease modification (D) 2018-10-17 2018-10-17 IMATINIB 2 N 220000151 IMATINIB
220009843 220004057 1.67 0 Disease modification (D) 2015-11-11 2015-11-13 IMATINIB 2 N 220000211 IMATINIB
220009844 220004060 1.6 0 Disease modification (D) 2016-11-27 2016-11-27 IMATINIB N N 220000223 IMATINIB
220009845 220004060 null 115 Disease modification (D) 2016-09-19 2016-09-19 Imatinib 400mg 2 N 220000223 IMATINIB
220009846 220004062 null null Disease modification (D) 2014-04-29 2014-04-29 IMATINIB 02 N 220000242 IMATINIB
220009847 220004065 null 84.2 Disease modification (D) 2013-05-14 2013-05-15 IMATINIB N N 220000355 IMATINIB
220009848 220004066 1.82 0 Palliative (P) 2017-04-22 2017-06-06 Imatinib 400mg N N 220000374 IMATINIB
220009849 220004067 0 0 Curative (C) 2013-03-31 2014-01-02 IMATINIB N N 220000374 IMATINIB
220009850 220004067 null 154.1 Palliative (P) 2017-11-11 2017-11-11 IMATINIB 02 N 220000374 IMATINIB
220009851 220004067 0 0 Curative (C) 2013-09-14 2013-09-14 Imatinib 400mg 02 N 220000374 IMATINIB
220009852 220004068 1.73 0 Disease modification (D) 2017-04-14 2017-04-18 IMATINIB 02 N 220000450 IMATINIB
220009854 220004074 null 83.6 Curative (C) 2018-04-16 2018-04-18 IMATINIB 2 N 220000538 IMATINIB
220009855 220004075 0 null Palliative (P) null 2013-12-25 IMATINIB N null 220000633 IMATINIB
220009856 220004077 1.77 78.2 null 2016-06-04 2016-11-06 IMATINIB 2 N 220000633 IMATINIB
220009857 220004079 0 null Curative (C) 2014-01-10 2014-01-10 IMATINIB 99 null 220000650 IMATINIB
220009859 220004080 null 52.1 Curative (C) 2014-01-29 2014-01-29 IMATINIB 02 N 220000676 IMATINIB
220009862 220004082 0 72 Curative (C) 2018-09-03 2018-09-06 IMATINIB N N 220000723 IMATINIB